Product information

Moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy

Moderate to severe plaque psoriasis in pediatric patients 6 years and older who are candidates for systemic therapy or phototherapy

Adult patients with active psoriatic arthritis when the response to previous DMARD therapy has been inadequate. COSENTYX® can be used alone or in combination with methotrexate

Adult patients with active ankylosing spondylitis who have responded inadequately to conventional therapy

Active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated CRP and/or MRI evidence in adults who have responded inadequately or are ...

Active enthesitis-related arthritis and active juvenile psoriatic arthritis in patients 6 years and older whose disease has responded inadequately to, or who cannot tolerate, ...